Ignite Creation Date:
2024-05-05 @ 4:55 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00340899
Status:
COMPLETED
Last Update Posted:
2023-02-24
First Post:
2006-06-19
Brief Title:
Biological Markers of Disease in the Prediction of Preterm Delivery Preeclampsia and Intra-Uterine Growth Retardation A Longtitudinal Study
Sponsor:
Eunice Kennedy Shriver National Institute of Child Health and Human Development NICHD
Organization:
National Institutes of Health Clinical Center CC
Study Overview
Official Title:
Biological Markers of Disease in the Prediction of Preterm Delivery Preeclampsia and Intra-Uterine Growth Restriction A Longitudinal Study
Status:
COMPLETED
Status Verified Date:
2023-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Preterm delivery preeclampsia and intrauterine growth restriction are leading causes of perinatal morbidity and mortality Efforts to treat these syndromes have not been effective most likely becuase these obstetric complications are the clinical expression of adaptive mechanisms of host defense developed in response to pathologic insults Since the ultimate pathologic basis of disease is unclear therapy for these syndromes has been largely directed at symptoms which appear late in the development of the disease The main purpose of this study is to perform an early and comprehensive exploration of maternal and fetal factors that predict the subsequent develpment of these obstetrice complications so that early medical interventions may be tested in patients at high and low risk for adverse perinatal outcome
Detailed Description:
Preterm delivery preeclampsia and intrauterine growth restriction are leading causes of perinatal morbidity and mortality Efforts to treat these syndromes have not been effective most likely because these obstetric complications are the clinical expression of adaptive mechanisms of host defense developed in response to pathologic insults Since the ultimate pathologic basis of disease is unclear therapy for these syndromes has been largely directed at symptoms which appear late in the development of the disease The main purpose of this study is to perform an early and comprehensive exploration of maternal and fetal factors that predict the subsequent development of these obstetric complications so that early medical interventions may be tested in patients at high and low risk for adverse perinatal outcome
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| OH97-CH-N067 | None | None | None |